High-dose-rate brachytherapy for the treatment of recalcitrant keloids: A unique, effective treatment protocol

Plastic and Reconstructive Surgery

Volumn 134, Issue 3, 2014, Pages 527-534

  Van Leeuwen, Michiel C E ^a   Stokmans, Suzanne C ^a   Bulstra, Anne Eva J ^a   Meijer, Otto W M ^a   Van Leeuwen, Paul A M ^a   Niessen, Frank B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; BRACHYTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; KELOID; MALE; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRACHYTHERAPY; CLINICAL PROTOCOLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KELOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907304366     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000415     Document Type: Article

References (41)

1. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg. 1999;104:1435-1458.
2. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006;297:433-438.
3. Bischof M, Krempien R, Debus J, Treiber M. Postoperative electron beam radiotherapy for keloids: Objective findings and patient satisfaction in self-assessment. Int J Dermatol. 2007;46:971-975.
4. Mustoe TA, Cooter RD, Gold MH, et al.; International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-571.
5. Lee SS, Yosipovitch G, Chan YH, Goh CL. Pruritus, pain, and small nerve fiber function in keloids: A controlled study. J Am Acad Dermatol. 2004;51:1002-1006.
6. Chike-Obi CJ, Cole PD, Brissett AE. Keloids: Pathogenesis, clinical features, and management. Semin Plast Surg. 2009;23:178-184.
7. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113-125.
8. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: A review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S63-S97.
9. Arneja JS, Singh GB, Dolynchuk KN, Murray KA, Rozzelle AA, Jones KD. Treatment of recurrent earlobe keloids with surgery and high-dose-rate brachytherapy. Plast Reconstr Surg. 2008;121:95-99.
10. Viani GA, Stefano EJ, Afonso SL, De Fendi LI. Postoperative strontium-90 brachytherapy in the prevention of keloids: Results and prognostic factors. Int J Radiat Oncol Biol Phys. 2009;73:1510-1516.
11. Kovalic JJ, Perez CA. Radiation therapy following keloidectomy: A 20-year experience. Int J Radiat Oncol Biol Phys. 1989;17:77-80.
12. Garg MK, Weiss P, Sharma AK, et al. Adjuvant high dose rate brachytherapy (Ir-192) in the management of keloids which have recurred after surgical excision and external radiation. Radiother Oncol. 2004;73:233-236.
13. Draaijers LJ, Tempelman FR, Botman YA, et al. The patient and observer scar assessment scale: A reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004;113:1960-1965; discussion 1966.
14. van der Wal MB, Tuinebreijer WE, Bloemen MC, Verhaegen PD, Middelkoop E, van Zuijlen PP. Rasch analysis of the Patient and Observer Scar Assessment Scale (POSAS) in burn scars. Qual Life Res. 2012;21:13-23.
15. Nicholas RS, Falvey H, Lemonas P, et al. Patient-related keloid scar assessment and outcome measures. Plast Reconstr Surg. 2012;129:648-656.
16. Peacock EE Jr, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J. 1970;63:755-760.
17. Mancini RE, Quaife JV. Histogenesis of experimentally produced keloids. J Invest Dermatol. 1962;38:143-181.
18. Arnault JP, Peiffert D, Latarche C, Chassagne JF, Barbaud A, Schmutz JL. Keloids treated with postoperative Iridium 192 brachytherapy: A retrospective study. J Eur Acad Dermatol Venereol. 2009;23:807-813.
19. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869-871.
20. Cosman B, Wolff M. Bilateral earlobe keloids. Plast Reconstr Surg. 1974;53:540-543.
21. Van de Kar AL, Kreulen M, van Zuijlen PPM, Oldenburger F. The results of surgical excision and adjuvant irradiation for therapy-resistant keloids: A prospective clinical outcome study. Plast Reconstr Surg. 2007;119:2248-2254.
22. Dinh Q, Veness M, Richards S. Role of adjuvant radiotherapy in recurrent earlobe keloids. Australas J Dermatol. 2004;45:162-166.
23. Ragoowansi R, Cornes PG, Moss AL, Glees JP. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg. 2003;111:1853-1859.
24. Veen RE, Kal HB. Postoperative high-dose-rate brachytherapy in the prevention of keloids. Int J Radiat Oncol Biol Phys. 2007;69:1205-1208.
25. Guix B, Henríquez I, Andrés A, Finestres F, Tello JI, Martínez A. Treatment of keloids by high-dose-rate brachytherapy: A seven-year study. Int J Radiat Oncol Biol Phys. 2001;50:167-172.
26. Kuribayashi S, Miyashita T, Ozawa Y, et al. Post-keloidectomy irradiation using high-dose-rate superficial brachytherapy. J Radiat Res. 2011;52:365-368.
27. Rio E, Bardet E, Peuvrel P, Pannier M, Dreno B. Perioperative interstitial brachytherapy for recurrent keloid scars. Plast Reconstr Surg. 2009;124:180e-181e.
28. Stahl S, Barnea Y, Weiss J, et al. Treatment of earlobe keloids by extralesional excision combined with preoperative and postoperative "sandwich" radiotherapy. Plast Reconstr Surg. 2010;125:135-141.
29. Escarmant P, Zimmermann S, Amar A, et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys. 1993;26:245-251.
30. Kantorowitz DA, Miller GJ, Ferrara JA, Ibbott GS, Fisher R, Ahrens CR. Preoperative versus postoperative irradiation in the prophylaxis of heterotopic bone formation in rats. Int J Radiat Oncol Biol Phys. 1990;19:1431-1438.
31. Kantorowitz DA, Muff NS. Preoperative vs. postoperative radiation prophylaxis of heterotopic ossification: A rural community hospital's experience. Int J Radiat Oncol. 1998;40:171-176.
32. Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys. 2006;65:1289-1299.
33. Kal HB, Veen RE, Jürgenliemk-Schulz IM. Dose-effect relationships for recurrence of keloid and pterygium after surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2009;74:245-251.
34. De Lorenzi F, Tielemans HJ, van der Hulst RR, et al. Is the treatment of keloid scars still a challenge in 2006? Ann Plast Surg. 2007;58:186-192.
35. Ogawa R, Yoshitatsu S, Yoshida K, Miyashita T. Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg. 2009;124:1196-1201.
36. Kenney JA Jr. Pigmentary disorders in black skin. Clin Dermatol. 1989;7:1-10.
37. Fraunholz IB, Gerstenhauer A, Böttcher HD. Results of postoperative (90)Sr radiotherapy of keloids in view of patients' subjective assessment. Strahlenther Onkol. 2005;181:724-729.
38. Bijlard E, Timman R, Verduijn GM, et al. Intralesional cryotherapy versus excision and corticosteroids or brachytherapy for keloid treatment: Study protocol for a randomised controlled trial. Trials 2013;14:439.
39. Emad M, Omidvari S, Dastgheib L, Mortazavi A, Ghaem H. Surgical excision and immediate postoperative radiotherapy versus cryotherapy and intralesional steroids in the management of keloids: A prospective clinical trial. Med Princ Pract. 2010;19:402-405.
40. Durani P, Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg. 2008;61:4-17.
41. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003;111:1841-1852.